Want to join the conversation?
$MKC reported stronger earnings in 3Q16, helped by higher operating income, including the impact of special charges, as well as a favorable tax rate and lower shares outstanding, compared to 3Q15. Net income was $127.7MM or $1.00 per diluted share versus $97.6MM or $0.76 per diluted share last year. Net sales grew 3% from last year to $1.09Bil.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)